A Potent Combination: Applying Six Sigma and ICH Q9 for High-Potency Drug Processes

Waterford-based EirGen Pharma Managing Director Patsy Carney discusses the technologies behind high-potency drug containment, Six Sigma initiatives and the company's recent work with FDA on the Risk MaPP guidance.